Comprehensive review on the drug delivery options being used for endometriosis and uterine fibroids.
What are the medications and delivery methods currently being used and developed for endometriosis and uterine fibroids?
Key Points Lay Summary
Environmental toxins and endometriosis
Several studies have suggested that exposure to persistent pollutant, polychlorinated biphenyls (PCBs), may increase the risk of developing endometriosis
Key Points Lay Summary
Women with endometriosis are increasingly seeking alternative medical therapies for symptom relief
Observing changes of alternative medical use in relation to various menstrual problems among women with and without endometriosis.
Key Points Lay Summary
Endometriosis Fertility Index Anticipates Pregnancy in Women with Endometriosis
Endometriosis fertility index (EFI) is a reliable substitute for the revised American Fertility Society (rAFS) classification system when it comes to predicting pregnancy in a women with endometriosis post-surgery.
Key Points Lay Summary
Best Time for IVF Between 7 and 25 Months Post Surgery Study Suggests
Researchers from Canada analyzed more than 400 women.
Key Points Lay Summary
Arcyriaflavin A Decreases Endometriosis Cell Viability and Proliferation
Arcyriaflavin A shows promise as a potential therapy to treat Endometriosis.
Key Points Lay Summary
A Systematic Review of Guidelines for Diagnosis and Management of Endometriosis
Quality Control of Guidelines for Diagnosis and Management of Endometriosis
Key Points Lay Summary
First-line surgery followed by ART versus ART alone among women with colon-involving endometriosis.
The benefit of first-line surgery on fertility rates among women with colon-involving endometriosis who undergo ART.
Key Points Lay Summary